215 related articles for article (PubMed ID: 19188850)
21. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
Stearns V; Beebe KL; Iyengar M; Dube E
JAMA; 2003 Jun; 289(21):2827-34. PubMed ID: 12783913
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of sertraline for controlling hot flashes in women with or at high risk of developing breast cancer.
Wu MF; Hilsenbeck SG; Tham YL; Kramer R; Elledge RM; Chang JC; Friedman LC
Breast Cancer Res Treat; 2009 Nov; 118(2):369-75. PubMed ID: 19495957
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen-induced hot flashes.
Loprinzi CL; Zahasky KM; Sloan JA; Novotny PJ; Quella SK
Clin Breast Cancer; 2000 Apr; 1(1):52-6. PubMed ID: 11899390
[TBL] [Abstract][Full Text] [Related]
24. Venlafaxine in management of hot flashes in women with breast cancer: a systematic review and meta-analysis.
Ramaswami R; Villarreal MD; Pitta DM; Carpenter JS; Stebbing J; Kalesan B
Breast Cancer Res Treat; 2015 Jul; 152(2):231-7. PubMed ID: 26067931
[TBL] [Abstract][Full Text] [Related]
25. Tamoxifen-associated hot flash severity is inversely correlated with endoxifen concentration and CYP3A4*22.
Baxter SD; Teft WA; Choi YH; Winquist E; Kim RB
Breast Cancer Res Treat; 2014 Jun; 145(2):419-28. PubMed ID: 24744093
[TBL] [Abstract][Full Text] [Related]
26. Acupuncture for the treatment of hot flashes in patients with breast cancer receiving antiestrogen therapy: a pilot study in Korean women.
Jeong YJ; Park YS; Kwon HJ; Shin IH; Bong JG; Park SH
J Altern Complement Med; 2013 Aug; 19(8):690-6. PubMed ID: 23383974
[TBL] [Abstract][Full Text] [Related]
27. A pilot trial of paroxetine for the treatment of hot flashes and associated symptoms in women with breast cancer.
Weitzner MA; Moncello J; Jacobsen PB; Minton S
J Pain Symptom Manage; 2002 Apr; 23(4):337-45. PubMed ID: 11997203
[TBL] [Abstract][Full Text] [Related]
28. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
29. Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy.
Jin Y; Hayes DF; Li L; Robarge JD; Skaar TC; Philips S; Nguyen A; Schott A; Hayden J; Lemler S; Storniolo AM; Flockhart DA; Stearns V
J Clin Oncol; 2008 Dec; 26(36):5849-54. PubMed ID: 19018086
[TBL] [Abstract][Full Text] [Related]
30. Randomized, double-blind, placebo-controlled crossover trials of venlafaxine for hot flashes after breast cancer.
Carpenter JS; Storniolo AM; Johns S; Monahan PO; Azzouz F; Elam JL; Johnson CS; Shelton RC
Oncologist; 2007 Jan; 12(1):124-35. PubMed ID: 17227907
[TBL] [Abstract][Full Text] [Related]
31. Effect of soy phytoestrogens on hot flashes in postmenopausal women with breast cancer: a randomized, controlled clinical trial.
Van Patten CL; Olivotto IA; Chambers GK; Gelmon KA; Hislop TG; Templeton E; Wattie A; Prior JC
J Clin Oncol; 2002 Mar; 20(6):1449-55. PubMed ID: 11896091
[TBL] [Abstract][Full Text] [Related]
32. Levetiracetam for the treatment of hot flashes: a phase II study.
Thompson S; Bardia A; Tan A; Barton DL; Kottschade L; Sloan JA; Christensen B; Smith D; Loprinzi CL
Support Care Cancer; 2008 Jan; 16(1):75-82. PubMed ID: 17598133
[TBL] [Abstract][Full Text] [Related]
33. Quantitative comparison of drug efficacy in treating hot flashes in patients with breast cancer.
Li T; Yang J; Lv Y; Yin F; Xu L; Liu H; Zheng Q; Li L
Breast Cancer Res Treat; 2019 Feb; 173(3):511-520. PubMed ID: 30390215
[TBL] [Abstract][Full Text] [Related]
34. Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine.
Simon JA; Chandler J; Gottesdiener K; Lazarus N; He W; Rosenberg E; Wagner JA; Denker AE
Menopause; 2014 Sep; 21(9):938-44. PubMed ID: 24569618
[TBL] [Abstract][Full Text] [Related]
35. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis.
Nelson HD; Vesco KK; Haney E; Fu R; Nedrow A; Miller J; Nicolaidis C; Walker M; Humphrey L
JAMA; 2006 May; 295(17):2057-71. PubMed ID: 16670414
[TBL] [Abstract][Full Text] [Related]
36. Pilot evaluation of black cohosh for the treatment of hot flashes in women.
Pockaj BA; Loprinzi CL; Sloan JA; Novotny PJ; Barton DL; Hagenmaier A; Zhang H; Lambert GH; Reeser KA; Wisbey JA
Cancer Invest; 2004; 22(4):515-21. PubMed ID: 15565808
[TBL] [Abstract][Full Text] [Related]
37. Randomized trial of black cohosh for the treatment of hot flashes among women with a history of breast cancer.
Jacobson JS; Troxel AB; Evans J; Klaus L; Vahdat L; Kinne D; Lo KM; Moore A; Rosenman PJ; Kaufman EL; Neugut AI; Grann VR
J Clin Oncol; 2001 May; 19(10):2739-45. PubMed ID: 11352967
[TBL] [Abstract][Full Text] [Related]
38. A pilot phase II trial of magnesium supplements to reduce menopausal hot flashes in breast cancer patients.
Park H; Parker GL; Boardman CH; Morris MM; Smith TJ
Support Care Cancer; 2011 Jun; 19(6):859-63. PubMed ID: 21271347
[TBL] [Abstract][Full Text] [Related]
39. The addition of hormone therapy to tamoxifen does not prevent hot flashes in women at high risk for developing breast cancer.
Osborne CR; Duncan A; Sedlacek S; Paul D; Holmes F; Vukelja S; Kasper M; Wilks S; Schneider A; McGee R; Meyer WG; O'Shaughnessy JA
Breast Cancer Res Treat; 2009 Aug; 116(3):521-7. PubMed ID: 19139988
[TBL] [Abstract][Full Text] [Related]
40. Gabapentin for hot flashes in 420 women with breast cancer: a randomised double-blind placebo-controlled trial.
Pandya KJ; Morrow GR; Roscoe JA; Zhao H; Hickok JT; Pajon E; Sweeney TJ; Banerjee TK; Flynn PJ
Lancet; 2005 Sep 3-9; 366(9488):818-24. PubMed ID: 16139656
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
